New Instrument Simplifies Structural Biology Workflows
OXFORD — Refeyn has unveiled its latest innovation, the MyMass mass photometer, aimed at enhancing sample quality assessment in structural biology. The compact device was launched this week in Oxford and is designed to verify sample quality before researchers proceed with expensive and time-consuming experiments.
The MyMass instrument allows scientists to quickly evaluate sample purity, homogeneity, and oligomerization states in solution. According to Refeyn, this helps avoid failures in costly processes like cryo-electron microscopy and surface plasmon resonance. Gerry Mackay, CEO of Refeyn, stated that the device makes mass photometry technology more accessible to researchers, enabling better drug discovery and development.
Impact on Research and Development
Fiona Coats, Chief Product and Marketing Officer at Refeyn, highlighted the importance of the MyMass in empowering researchers to assess sample readiness quickly. She noted that the tool offers an intuitive workflow and onboard data analysis, making it easier for labs to integrate into their processes. The launch of MyMass comes as the demand for efficient and accurate sample quality checks grows, driven by advances in drug design and biotechnology. As the field of structural biology continues to evolve, ensuring the quality of samples becomes ever more critical. MyMass provides an effective solution, offering precise measurements that can significantly reduce the risk of errors in subsequent experiments.
The MyMass device supports a wide array of applications, including protein analysis, complex formation studies, and the evaluation of molecular interactions. This versatility makes it a valuable tool not only for academic research but also for pharmaceutical companies focusing on developing new therapies. By offering detailed insights into sample characteristics, MyMass helps streamline the research process, saving both time and resources.
Refeyn’s commitment to advancing scientific tools is reflected in the MyMass’s user-friendly design and robust performance. As more laboratories adopt this technology, it is expected to play a pivotal role in shaping the future of research in structural biology and related fields.
Source: newshub.medianet.com.au
Last updated: 4 April 2026, 6:39 pm
